Related Experiment Video
Updated: Jan 16, 2026

08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.5K
Enabling Open Machine Learning of Deoxyribonucleic Acid-Encoded Library Selections to Accelerate the Discovery of
James Wellnitz1, Shabbir Ahmad2, Nabin Bagale3
1Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina 27516, United States.
Journal of Medicinal Chemistry
|October 6, 2025
Summary
This study introduces an automated, open-source machine learning framework for DNA-encoded library screening. It enables reproducible ligand discovery using public data, matching proprietary method performance.
Area of Science:
- Drug discovery and development
- Computational chemistry
- Bioinformatics
Background:
- Machine learning (ML) is vital for DNA-encoded library (DEL) screening in ligand discovery.
- Proprietary datasets limit accessibility and reproducibility in DEL-ML applications.
- There is a need for open and automated frameworks to democratize drug discovery.
Purpose of the Study:
- To present the first fully open, automated DEL-ML framework.
- To enable reproducible and accessible drug discovery using public DEL data.
- To demonstrate the efficacy of open-source approaches in ligand discovery.
Main Methods:
- Developed an automated workflow for ML model training, virtual screening, and compound selection.
- Utilized public DEL datasets and chemical fingerprints for model development.
- Applied the framework to identify WDR91 binders using large-scale virtual screening.
Main Results:
- Identified 50 candidate compounds for WDR91.
- Experimentally validated seven novel binders with dissociation constants in the micromolar range (2.7–21 μM).
- The open-source framework demonstrated performance comparable to proprietary methods.
Conclusions:
- Public DEL data can support robust ML-driven ligand discovery.
- The open-source DEL-ML framework enhances transparency and accessibility in drug development.
- This approach fosters broader community participation in discovering novel therapeutics.

